The Christian Post on MSN21h
Sight to the blind? Elon Musk looks to expand Neuralink applications to 'telepathy,' 'telekinesis'
Elon Musk is looking to expand Neuralink applications to telepathy and telekinesis The Tesla and X CEO brain implant venture, ...
Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights
August 15, 2025, is the FDA PDUFA goal date for TNX-102 SL for the management of fibromyalgia; If approved, TNX-102 SL would become the first new ...
Tonix Pharmaceuticals Holding Corp.: Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights
August 15, 2025, is the FDA PDUFA goal date for TNX-102 SL for the management of fibromyalgia; If approved, TNX-102 SL would become the first new drug for treating fibromyalgia in more than 15 years ...
LawFuel8h
Kirkland & Ellis Crushes It Again, Hitting Mind-Blowing $8.8B Revenue
Kirkland & Ellis shattered Big Law revenue records with an unprecedented $8.8 billion performance, widening the gap with ...
New data on investigational therapy for thymidine kinase 2 deficiency presented at Muscular Dystrophy Association (MDA) 2025 Conference
UCB, a global biopharmaceutical company, today announced positive data from studies involving its investigational pyrimidine nucleoside therapy, doxecitine (dC) and doxribtimine (dT), in people living ...